↓ Skip to main content

Cochrane Database of Systematic Reviews

Pentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infants

Overview of attention for article published in Cochrane database of systematic reviews, November 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
140 Mendeley
Title
Pentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infants
Published in
Cochrane database of systematic reviews, November 2014
DOI 10.1002/14651858.cd010018.pub2
Pubmed ID
Authors

Sven M Schulzke, Siree Kaempfen, Sanjay K Patole

Abstract

Bronchopulmonary dysplasia (BPD) is a common complication in preterm infants. BPD is associated with poor long-term respiratory and neurodevelopmental outcome and increased mortality. The prophylactic use of agents that modulate inflammation such as pentoxifylline, a synthetic methylxanthine and phosphodiesterase inhibitor, may reduce the incidence of BPD.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 140 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Unknown 139 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 15%
Researcher 18 13%
Student > Bachelor 18 13%
Student > Ph. D. Student 13 9%
Student > Doctoral Student 10 7%
Other 25 18%
Unknown 35 25%
Readers by discipline Count As %
Medicine and Dentistry 51 36%
Nursing and Health Professions 19 14%
Psychology 8 6%
Social Sciences 6 4%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Other 16 11%
Unknown 35 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 December 2014.
All research outputs
#14,312,523
of 21,321,365 outputs
Outputs from Cochrane database of systematic reviews
#10,512
of 12,035 outputs
Outputs of similar age
#201,720
of 345,922 outputs
Outputs of similar age from Cochrane database of systematic reviews
#218
of 238 outputs
Altmetric has tracked 21,321,365 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,035 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.0. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,922 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 238 others from the same source and published within six weeks on either side of this one. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.